MULTIDISCIPLINARY GENE THERAPY EDUCATION – RECOMBINANT ADENO-ASSOCIATED VIRUS (RAAV)

PFIZER, S.A

Object

Topic: Rare diseases.

Destination: Aid for the financing of educational initiatives, aimed at health professionals, that improve the medical and scientific understanding of gene therapy with recombinant adeno-associated virus (RAAV) to help prepare multidisciplinary teams for the integration of gene therapy with rAAV in the treatment of rare diseases and promote the preparation of gene therapy centers with institutional training and / or multidisciplinary teams.

Budget: $50,000/project.

Duration: Not indicated.

Are you interested in this call?

Are you interested?

Fill out the form below to receive more information: